產(chǎn)品屬性：
產(chǎn)品名稱(chēng) | Lapaquistat acetate |
規(guī)格 | 10mM*mL in DMSO、1mg、5mg |
貨號(hào) | EY-01Y11783 |
Cas No.: 189060-13-7
別名: N/A
化學(xué)名: N/A
分子式: C33H41ClN2O9
分子量: 645.14
溶解度: DMSO: 46 mg/mL (71.30 mM)
儲(chǔ)存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述：
Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene[1]. Lapaquistat acetate (TAK-475) is originally intended use to Mevalonate Kinase Deficiency (MKD), it is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage[2].[1]. Stein EA, et al. Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. Circulation. 2011 May 10;123(18):1974-85.
[2]. Marcuzzi A, et al. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice. Curr Med Chem. 2018;25(24):2783-2796.
特別提醒公司產(chǎn)品僅供科研使用
